Related references
Note: Only part of the references are listed.Next-Generation Proteomics-Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis
Jungyo Suh et al.
CANCER RESEARCH AND TREATMENT (2022)
Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma
Chen Chen et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2022)
Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer patients
Ko Igami et al.
CANCER SCIENCE (2022)
DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?
Nuno Tiago Tavares et al.
CANCERS (2022)
Alpha-2-macroglobulin as a novel diagnostic biomarker for human bladder cancer in urinary extracellular vesicles
Jisu Lee et al.
FRONTIERS IN ONCOLOGY (2022)
Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer
Hao Lin et al.
BMC CANCER (2021)
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
Richard J. Sylvester et al.
EUROPEAN UROLOGY (2021)
Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN
Guang Shan et al.
CELLULAR ONCOLOGY (2021)
Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker
Xuan-Mei Piao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The genetic source tracking of human urinary exosomes
Qingfu Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis
Guangyue Luo et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)
Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers
Eisuke Tomiyama et al.
CANCER SCIENCE (2021)
Secreted Extracellular Vesicle Molecular Cargo as a Novel Liquid Biopsy Diagnostics of Central Nervous System Diseases
Sara Monteiro-Reis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma
Jose Pedro Sequeira et al.
CANCERS (2021)
Harnessing the therapeutic potential of extracellular vesicles for cancer treatment
Ying Zhang et al.
SEMINARS IN CANCER BIOLOGY (2021)
Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances
Catarina Lourenco et al.
CANCERS (2021)
Combination of Urine Exosomal mRNAs and lncRNAs as Novel Diagnostic Biomarkers for Bladder Cancer
Haiming Huang et al.
FRONTIERS IN ONCOLOGY (2021)
Urinary extracellular vesicles: a rising star in bladder cancer management
Fumihiko Urabe et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)
Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression
Ziming Jiang et al.
CELL COMMUNICATION AND SIGNALING (2021)
Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors
Olaf Stromme et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2021)
Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer
Amal S. El-Shal et al.
MOLECULAR BIOLOGY REPORTS (2021)
Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls
Gokce Gullu Amuran et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2020)
Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells
Xinbao Yin et al.
CELL BIOLOGY INTERNATIONAL (2020)
DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
Vera Constancio et al.
CELLS (2020)
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
Elaine Kilgour et al.
CANCER CELL (2020)
Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles
Manuel Castanheira de Oliveira et al.
CANCERS (2020)
Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
Martina Minoli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Small Non-Coding RNA Profiling in Plasma Extracellular Vesicles of Bladder Cancer Patients by Next-Generation Sequencing: Expression Levels of miR-126-3p and piR-5936 Increase with Higher Histologic Grades
Alexandru A. Sabo et al.
CANCERS (2020)
Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics
Dongbin Yang et al.
THERANOSTICS (2020)
Exosomes: biogenesis, biologic function and clinical potential
Yuan Zhang et al.
CELL AND BIOSCIENCE (2019)
Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
Laura M. Doyle et al.
CELLS (2019)
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2019)
MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer
Sophie Baumgart et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Enrichment of Exosome-Like Extracellular Vesicles from Plasma Suitable for Clinical Vesicular miRNA Biomarker Research
Sohee Moon et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Evaluation of serum exosomal LncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer
Shujun Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Technical challenges of working with extracellular vesicles
Marcel I. Ramirez et al.
NANOSCALE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer
Yao Zhan et al.
MOLECULAR CANCER (2018)
PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial-Mesenchymal Transition
Xin Chen et al.
CLINICAL CANCER RESEARCH (2018)
Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression
Rui Zheng et al.
MOLECULAR CANCER (2018)
Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Blader Cancer Diagnosis and Prognosis
Jiansong Wang et al.
MEDICAL SCIENCE MONITOR (2018)
Urine exosome gene expression of cancer-testis antigens for prediction of bladder carcinoma
Fatemeh Yazarlou et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Clotilde Thery et al.
JOURNAL OF EXTRACELLULAR VESICLES (2018)
Exosome-Based Cell-Cell Communication in the Tumor Microenvironment
Joana Maia et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression
Zoraida Andreu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1
Mei Xue et al.
MOLECULAR CANCER (2017)
MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma
Kyosuke Matsuzaki et al.
ONCOTARGET (2017)
Liquid Biopsy: Current Status and Future Perspectives
Sonja Mader et al.
ONCOLOGY RESEARCH AND TREATMENT (2017)
Bladder cancer
Oner Sanli et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Prospective evaluation of anxiety, pain, and embarrassment associated with cystoscopy and urodynamic testing in clinical practice
Xavier Biardeau et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2017)
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis
Ming Yin et al.
ONCOLOGIST (2016)
Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer
Christopher R. Silvers et al.
ONCOTARGET (2016)
Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes
Claudia Berrondo et al.
PLOS ONE (2016)
Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial Carcinoma
Shih-Yi Lin et al.
SCIENTIFIC REPORTS (2016)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al.
NATURE (2015)
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
Bernd J. Schmitz-Draeger et al.
UROLOGIA INTERNATIONALIS (2015)
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
Faysal A. Yafi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
The burden of bladder cancer care: direct and indirect costs
Matthew Mossanen et al.
CURRENT OPINION IN UROLOGY (2014)
Bladder Cancer Exosomes Contain EDIL-3/Del1 and Facilitate Cancer Progression
Carla J. Beckham et al.
JOURNAL OF UROLOGY (2014)
Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer
Bernd J. Schmitz-Draeger et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Considerations on the use of urine markers in the management of with high-grade non-muscle-invasive bladder cancer
Ashish M. Kamat et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
A Pilot Study on the Potential of RNA-Associated to Urinary Vesicles as a Suitable Non-Invasive Source for Diagnostic Purposes in Bladder Cancer
Amparo Perez et al.
CANCERS (2014)
Recurrence of high-risk bladder cancer: A population-based analysis
Karim Chamie et al.
CANCER (2013)
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Maximilian Burger et al.
EUROPEAN UROLOGY (2013)
Extracellular vesicles: Exosomes, microvesicles, and friends
Graca Raposo et al.
JOURNAL OF CELL BIOLOGY (2013)
Should Follow-up Cystoscopy in Bacillus Calmette-Guerin-Treated Patients Continue After Five Tumour-Free Years?
Sten Holmang et al.
EUROPEAN UROLOGY (2012)
Comparative and Targeted Proteomic Analyses of Urinary Microparticles from Bladder Cancer and Hernia Patients
Chien-Lun Chen et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Exosomes Released by Melanoma Cells Prepare Sentinel Lymph Nodes for Tumor Metastasis
Joshua L. Hood et al.
CANCER RESEARCH (2011)
Exosomes and Cancer: A Newly Described Pathway of Immune Suppression
Huang-Ge Zhang et al.
CLINICAL CANCER RESEARCH (2011)
Long-term Cancer-specific Survival in Patients with High-risk, Non-muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review
Sven van den Bosch et al.
EUROPEAN UROLOGY (2011)
Cancer Exosomes Trigger Fibroblast to Myofibroblast Differentiation
Jason Webber et al.
CANCER RESEARCH (2010)
Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology
Rudolf P. Talens et al.
FASEB JOURNAL (2010)
Environmental factors and genetic susceptibility promote urinary bladder cancer
Dimitrios Volanisa et al.
TOXICOLOGY LETTERS (2010)
Economic aspects of bladder cancer: what are the benefits and costs?
K. D. Sievert et al.
WORLD JOURNAL OF UROLOGY (2009)
Isolation and identification of potential urinary microparticle biomarkers of bladder cancer
David M. Slrnalley et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Clinical model of lifetime cost of treating bladder cancer and associated complications
Elenir B. C. Avritscher et al.
UROLOGY (2006)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
The economic consequences of prostate and bladder cancer in the UK
VK Sangar et al.
BJU INTERNATIONAL (2005)
The health economics of bladder cancer - A comprehensive review of the published literature
MF Botteman et al.
PHARMACOECONOMICS (2003)
The community-based morbidity of flexible cystoscopy
DM Burke et al.
BJU INTERNATIONAL (2002)
Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome
HW Herr
JOURNAL OF UROLOGY (2000)
Share Paper
